Skip to content
Search

Latest Stories

Professor Colin Melville to retire from GMC next summer

Professor Colin Melville to retire from GMC next summer

The GMC will start the recruitment process for his successor in September this year

Professor Colin Melville has announced his plan to retire as the Medical Director and Director of Education and Standards at the General Medical Council (GMC) next summer.

Professor Melville joined the GMC in 2017, transitioning from his role as head of Lancaster Medical School.


Before that, he held senior leadership roles at Warwick Medical School, Hull York Medical School, and North Yorkshire East Coast Foundation School.

Professor Melville said: “It has been a difficult decision to leave the GMC, which is a fantastic organisation with so many wonderful colleagues.

“I have had the privilege of overseeing some exciting changes to education and standards, but I believe now is the right for me to step back from a full-time executive role.

“And, of course, I am looking forward to doing some different things and having more time for family and friends.”

A registered doctor and former consultant in intensive care medicine, Professor Melville began his clinical career in 1983.

He was awarded Honorary Fellow of the Academy of Medical Educators in 2018 and became an Honorary Professor in Medical Education at Manchester University. In 2022, he was also appointed Visiting Professor at Anglia Ruskin University.

Professor Melville will retire at the end of June 2025 and the recruitment process for his successor will commence in September, with the position being advertised across the UK through an open campaign.

During his time at the GMC, Professor Melville has overseen the introduction of the Medical Licensing Assessment. He has been instrumental in the regulator’s work to address unfairness in undergraduate and postgraduate medical education, and played a key role in ensuring education and training was maintained during the pandemic.

Charlie Massey, Chief Executive and Registrar of the GMC, said: “While at the GMC Colin has provided strong leadership and strategic direction, and worked tirelessly to oversee an ambitious programme of work that has contributed to real change for the benefit of patients and doctors.

“We are hugely grateful for all that he has achieved, and will be sorry to see him leave.”

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less